|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.55 HKD | +1.35% |
|
+10.27% | +10.27% |
| 12:30pm | China Grants Registration Approval for Shanghai Shyndec Pharmaceutical Unit's Flu Injection | MT |
| May. 14 | China Traditional Chinese Medicine, Sinopharm Update on Privatization Process Status | MT |
Sinopharm Group Co. Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 147,265.8 million compared to CNY 145,517.77 million a year ago.
Net income was CNY 1,420.14 million compared to CNY 1,590.34 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +10.27% | 9.01B | |
| +19.13% | 71.7B | |
| -3.66% | 23.73B | |
| +11.24% | 8.72B | |
| -18.91% | 8.29B | |
| +16.00% | 5B | |
| +17.83% | 4.48B | |
| -2.11% | 4.08B | |
| -1.72% | 3.92B | |
| +27.53% | 3.8B |
SINOPHARM GROUP CO. LTD. 
